Prenetics Logo.jpg
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
March 02, 2023 07:00 ET | Prenetics Limited
LONDON and HONG KONG, March 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics...
Prenetics Logo.jpg
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 02, 2023 16:01 ET | Prenetics Limited
LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate...
Prenetics Logo.jpg
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
January 19, 2023 05:00 ET | Prenetics Limited
LONDON and HONG KONG, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure...
Prenetics Logo.jpg
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
January 10, 2023 06:00 ET | Prenetics Limited
Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global precision oncology marketFDA market authorization advances personalized...
Prenetics Logo.jpg
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
December 16, 2022 06:27 ET | Prenetics Limited
Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platformCancer genomics testing is now standard practice for cancer...
Prenetics Logo.jpg
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
November 30, 2022 09:15 ET | Prenetics Limited
LONDON and HONG KONG, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced that...
Prenetics Logo.jpg
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
November 10, 2022 08:00 ET | Prenetics Limited
LONDON and HONG KONG, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced its...
Prenetics Logo.jpg
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
September 09, 2022 09:02 ET | Prenetics Limited
Revenue of US$51.7 million in the second quarter of 2022Loss from operations of US$(17.9) million and adjusted EBITDA1 of US$6.5 million in the same periodRaises full year adjusted EBITDA guidance to...
Prenetics Logo.jpg
Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE”
June 06, 2022 06:45 ET | Prenetics Limited
LONDON and HONG KONG, June 06, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced its...
May 18 Adrian Danny Bell Ringing
Prenetics Rings the Opening Bell and Debuts on Nasdaq
May 18, 2022 18:30 ET | Prenetics Limited
Prenetics becomes the first Hong Kong unicorn to list on Nasdaq and its shares began trading on May 18 under ticker “PRE”At Least US$260M of Proceeds from the Business Combination, Cash and Trade...